Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NEuroStimulation for the Treatment of Mild Cognitive Impairment in Parkinson's Disease: an Acceptability Cross-over Study

NCT06399731 is registered in ClinicalTrials.gov with Amsterdam UMC as lead sponsor.

NCT NCT06399731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06399731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NEuroStimulation for the Treatment of Mild Cognitive Impairment in Parkinson's Disease: an Acceptability Cross-over Study
Lead sponsor
Amsterdam UMC
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2024
Completion date
May 1, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment, parkinson disease